Biosynthetic Technologies

About:

Biosynthetic Technologies manufactures biobased synthetic molecules that are made from organic fatty acids found in plant oils.

Website: http://biosynthetic.com/

Top Investors: U.S. Department of Agriculture, HG Ventures, Evonik Venture Capital, BP Ventures

Description:

Biosynthetic Technologies manufactures bio-based synthetic molecules that are made from organic fatty acids found in plant oils. These highly-functional biosynthetic oils have numerous uses in the lubricant, chemical, and cosmetics industries, often outperforming their petroleum counterparts in similar applications. In addition to their high-performance properties, these renewable oils are biodegradable and nontoxic. Finally, BT holds a broad portfolio of issued and pending patents protecting these novel biosynthetic oils. It was founded in 2006 and headquartered in Irvine, California.

Total Funding Amount:

$132M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Irvine, California, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)biosynthetic.com

Founders:

Jakob Bredsguard

Number of Employees:

11-50

Last Funding Date:

2022-02-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai